THE UNRAVELLING OF KODIAK SCIENCES

$KOD   Kodiak Sciences, Inc. (NASDAQ: KOD), a clinical-stage biotechnology Company focused on creating novel therapeutics for the treatment of retinal diseases announced disappointing results...read more